Published in TB and Outbreaks Week, June 27th, 2006
Study 1: The seroprevalence of HSV-1 and HSV-2 in Australia was determined.
"Studies demonstrating previous herpes simplex virus (HSV) type 2 infection as a risk factor for HIV transmission, and the development of a HSV vaccine candidate, have emphasized the need for worldwide population based studies of HSV seroprevalence.
"The only nationwide seroprevalence studies have been conducted in the United States. An Australia-wide, population based study of HSV-1 and HSV-2 seroprevalence was conducted, using serum and sociodemographic data collected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.